Insulin at Rs 7 will be a gamechanger for us: Biocon's Kiran Mazumdar-Shaw

'We are trying to develop a strategy where we could make people to stop using disposable plastic devices', said Shaw

Biopharmaceutical major Biocon has announced that it would reduce insulin prices to 10 cents (Rs 7) per day from $5 (Rs 350) for lower and middle-income countries, which account for 80 per cent of global diabetes cases. Kiran Mazumdar-Shaw, chairperson and managing director of the Bengaluru-headquartered firm, tells Samreen Ahmad that at 10 cents per day, the insulin business could be actually profitable if the company engages directly with the government. Edited excerpts:

Accessibility of insulin has been a major concern over the years due to its escalating price. Do you think the reducing the prices to 10 cents a day